ArticleOncology and therapy2022

Cost-Effectiveness of PD-L1 Testing in Non-Small Cell Lung Cancer (NSCLC) Using In Vitro Diagnostic (IVD) Versus Laboratory-Developed Test (LDT).

Jason T Hurwitz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.